![]()
|
|
||||||||
J. Biol. Chem., Vol. 263, Issue 22, 10754-10760, Aug, 1988
SS Broyles, L Yuen, S Shuman and B Moss
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892.
Partially purified DNA-dependent RNA polymerase from infectious vaccinia virus particles exhibits the following two activities: 1) specific transcription of double-stranded DNA templates containing vaccinia early promoters and 2) nonspecific transcription of single- stranded DNA templates. After further purification of the RNA polymerase, specific transcriptase activity was selectively diminished suggesting the loss of a transcription factor. In agreement with the latter hypothesis, transcriptase activity could be reconstituted by mixing the purified RNA polymerase with certain column fractions. A quantitative complementation assay was developed and used to locate the transcription factor during successive column chromatography steps. The factor eluted as a single peak of activity from single strand DNA- cellulose and phosphocellulose columns. An observation that the transcription factor binds specifically to vaccinia early promoter sequences was exploited in the final affinity chromatography steps. The purified factor was separated from all previously identified vaccinia enzymes and contained two polypeptides of Mr 77,000 and 82,000. A DNA- dependent ATPase activity also copurified with the transcription factor. Although a single template was used for assays during isolation, the purified factor stimulated transcription of three other early genes by 20-30-fold suggesting that it has a general role in conferring promoter specificity for initiation of early transcription.
This article has been cited by other articles:
![]() |
W. Resch and B. Moss The Conserved Poxvirus L3 Virion Protein Is Required for Transcription of Vaccinia Virus Early Genes J. Virol., December 1, 2005; 79(23): 14719 - 14729. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Katsafanas and B. Moss Vaccinia Virus Intermediate Stage Transcription Is Complemented by Ras-GTPase-activating Protein SH3 Domain-binding Protein (G3BP) and Cytoplasmic Activation/Proliferation-associated Protein (p137) Individually or as a Heterodimer J. Biol. Chem., December 10, 2004; 279(50): 52210 - 52217. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Broyles, M. Kremer, and B. A. Knutson Antiviral Activity of Distamycin A against Vaccinia Virus Is the Result of Inhibition of Postreplicative mRNA Synthesis J. Virol., February 15, 2004; 78(4): 2137 - 2141. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Broyles Vaccinia virus transcription J. Gen. Virol., September 1, 2003; 84(9): 2293 - 2303. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Broyles, X. Liu, M. Zhu, and M. Kremer Transcription Factor YY1 Is a Vaccinia Virus Late Promoter Activator J. Biol. Chem., December 10, 1999; 274(50): 35662 - 35667. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sanz and B. Moss Identification of a transcription factor, encoded by two vaccinia virus early genes, that regulates the intermediate stage of viral gene expression PNAS, March 16, 1999; 96(6): 2692 - 2697. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shors, J. G. Keck, and B. Moss Down Regulation of Gene Expression by the Vaccinia Virus D10 Protein J. Virol., January 1, 1999; 73(1): 791 - 796. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Gunasinghe, A. E. Hubbs, and C. F. Wright A Vaccinia Virus Late Transcription Factor with Biochemical and Molecular Identity to a Human Cellular Protein J. Biol. Chem., October 16, 1998; 273(42): 27524 - 27530. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xiang, D. A. Simpson, J. Spiegel, A. Zhou, R. H. Silverman, and R. C. Condit The Vaccinia Virus A18R DNA Helicase Is a Postreplicative Negative Transcription Elongation Factor J. Virol., September 1, 1998; 72(9): 7012 - 7023. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sanz and B. Moss A New Vaccinia Virus Intermediate Transcription Factor J. Virol., August 1, 1998; 72(8): 6880 - 6883. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Cassetti, M. Merchlinsky, E. J. Wolffe, A. S. Weisberg, and B. Moss DNA Packaging Mutant: Repression of the Vaccinia Virus A32 Gene Results in Noninfectious, DNA-Deficient, Spherical, Enveloped Particles J. Virol., July 1, 1998; 72(7): 5769 - 5780. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zhu, T. Moore, and S. S. Broyles A Cellular Protein Binds Vaccinia Virus Late Promoters and Activates Transcription In Vitro J. Virol., May 1, 1998; 72(5): 3893 - 3899. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Deng and S. Shuman Vaccinia NPH-I, a DExH-box ATPase, is the energy coupling factor for mRNA transcription termination Genes & Dev., February 15, 1998; 12(4): 538 - 546. [Abstract] [Full Text] |
||||
![]() |
X. Hu, E. J. Wolffe, A. S. Weisberg, L. J. Carroll, and B. Moss Repression of the A8L Gene, Encoding the Early Transcription Factor 82-Kilodalton Subunit, Inhibits Morphogenesis of Vaccinia Virions J. Virol., January 1, 1998; 72(1): 104 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Deng and S. Shuman An ATPase Component of the Transcription Elongation Complex Is Required for Factor-dependent Transcription Termination by Vaccinia RNA Polymerase J. Biol. Chem., November 15, 1996; 271(46): 29386 - 29392. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Deng, J. Hagler, and S. Shuman Factor-dependent Release of Nascent RNA by Ternary Complexes of Vaccinia RNA Polymerase J. Biol. Chem., August 9, 1996; 271(32): 19556 - 19562. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Myette and E. G. Niles Domain Structure of the Vaccinia Virus mRNA Capping Enzyme J. Biol. Chem., May 17, 1996; 271(20): 11936 - 11944. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Hagler and S Shuman A freeze-frame view of eukaryotic transcription during elongation and capping of nascent mRNA Science, February 21, 1992; 255(5047): 983 - 986. [Abstract] [PDF] |
||||
![]() |
M. R. Mohamed and E. G. Niles Interaction between Nucleoside Triphosphate Phosphohydrolase I and the H4L Subunit of the Viral RNA Polymerase Is Required for Vaccinia Virus Early Gene Transcript Release J. Biol. Chem., August 11, 2000; 275(33): 25798 - 25804. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Mohamed and E. G. Niles The Viral RNA Polymerase H4L Subunit Is Required for Vaccinia Virus Early Gene Transcription Termination J. Biol. Chem., June 1, 2001; 276(23): 20758 - 20765. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |